Role of Receptor for Advanced Glycation End-Products in Endometrial Cancer: A Review. [PDF]
Zglejc-Waszak K +3 more
europepmc +1 more source
Receptor of advanced glycation end-products axis and gallbladder cancer: A forgotten connection that we should reconsider. [PDF]
Rojas A +4 more
europepmc +1 more source
ABSTRACT Introduction Thinning of fat pads may elevate the risk of developing plantar foot ulcers potentially resulting in lower‐extremity amputations. Evaluating whether fat pad thickness is associated with plantar foot ulceration could aid in early risk detection. This study therefore aims to compare fat pad thickness between type 2 diabetes mellitus
Sem J. van den Nieuwenhof +4 more
wiley +1 more source
Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses. [PDF]
Cross K +5 more
europepmc +1 more source
Nε-(carboxymethyl)lysine promotes lipid uptake of macrophage via cluster of differentiation 36 and receptor for advanced glycation end products. [PDF]
Wang ZQ, Yao HP, Sun Z.
europepmc +1 more source
This study investigated Advanced Glycation End Products (AGEs), reflecting carbonyl stress from glycation and oxidation reactions, as potential biomarkers for identifying binge‐eating/purging behaviors in anorexia nervosa (AN). Finding revealed higher fingertip AGE levels in the binge‐eating/purging subtype (ANBP) compared to the restricting subtype ...
Kana Morimoto +8 more
wiley +1 more source
MP081RENAL AGEING AND GLYCATION: IMPLICATION OF RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS [PDF]
Thibault Tessier +7 more
openaire +1 more source
Membrane-bound receptor for advanced glycation end products (RAGE) is a stable biomarker of low-quality sperm. [PDF]
Browning J +6 more
europepmc +1 more source
Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps. [PDF]
Watanabe H +15 more
europepmc +1 more source
ABSTRACT Aims Achieving optimal glycaemic control remains a burden for many people with diabetes on intensive insulin treatment. The MELISSA trial aims to clinically validate the artificial intelligence (AI)‐based MELISSA system to support people with Type 1 diabetes on multiple daily insulin injections (MDI) with personalised insulin dose ...
Elisabeth J. den Brok +15 more
wiley +1 more source

